De novo tacrolimus-based immunosuppression reduces renal allograft fibrosis compared to neoral:: a prospective randomized clinical trial

被引：0
|
作者：
Murphy, GJ [1 ]
Waller, JR [1 ]
Sandford, R [1 ]
Nicholson, ML [1 ]
机构：
[1] Univ Leicester, Leicester Gen Hosp, Dept Surg, Leicester LE5 4PW, Leics, England
来源：
BRITISH JOURNAL OF SURGERY | 2002年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy
    Waller, JR
    Murphy, GJ
    Metcalfe, MS
    Sandford, RM
    Pattenden, CJ
    Nicholson, ML
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1587 - 1588
  • [2] Primary tacrolimus-based immunosuppression in renal allograft recipients: A single center experience
    Lye, WC
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1700 - 1701
  • [3] Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis
    Murphy, GJ
    Waller, JR
    Sandford, RS
    Furness, PN
    Nicholson, ML
    BRITISH JOURNAL OF SURGERY, 2003, 90 (06) : 680 - 686
  • [4] Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure
    Filler, G
    Womiloju, T
    Feber, J
    Lepage, N
    Christians, U
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (08) : 2005 - 2010
  • [5] A Randomised Controlled Trial to Investigate the Impact of Prolonged-Release Tacrolimus-Based Immunosuppression on Renal Function in De Novo Liver Transplantation
    Tisone, Giuseppe
    Trunecka, Pavel
    Klempnauer, Juergen
    HEPATOLOGY, 2013, 58 (06) : 1384A - 1385A
  • [6] A PROSPECTIVE TRIAL OF DIET AND EXERCISE TO IMPROVE GLUCOSE METABOLISM AND CARDIOVASCULAR RISK FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS-BASED IMMUNOSUPPRESSION
    Chadban, S.
    Whitman, G.
    Wyburn, K.
    Butcher, B.
    Rees, T.
    Russ, G.
    Mulley, W.
    Irish, A.
    Dunstan, D.
    Eris, J.
    NEPHROLOGY, 2012, 17 : 70 - 70
  • [7] A PROSPECTIVE TRIAL OF DIET AND EXERCISE TO IMPROVE GLUCOSE METABOLISM AND CARDIOVASCULAR RISK FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS-BASED IMMUNOSUPPRESSION
    Steven, Chadban
    Georgia, Whitman
    Kate, Wyburn
    Belinda, Butcher
    Tara, Rees
    Graeme, Russ
    William, Mulley
    Ashley, Irish
    David, Dunstan
    Josette, Eris
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (08): : A35 - A36
  • [8] A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation
    Grenda, R.
    Watson, A.
    Vondrak, K.
    Webb, N. J. A.
    Beattie, J.
    Fitzpatrick, M.
    Saleem, M. A.
    Trompeter, R.
    Milford, D. V.
    Moghal, N. E.
    Hughes, D.
    Perner, F.
    Friman, S.
    Van Damme-Lombaerts, R.
    Janssen, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (07) : 1666 - 1672
  • [9] Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
    Wen, X.
    Casey, M. J.
    Santos, A. H.
    Hartzema, A.
    Womer, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3202 - 3211
  • [10] Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression
    Sharma, A.
    Minz, M.
    Singh, S.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2414 - 2415
12345